We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine×マーケットリサーチセンター - List of Manufacturers, Suppliers, Companies and Products

medicine Product List

406～420 item / All 465 items

Displayed results
[Research Material] Global Market for Lung Cancer Treatment Drugs

[Research Material] Global Market for Lung Cancer Treatment Drugs

Global Market for Lung Cancer Treatments: Targeted Therapy, Immunotherapy, Chemotherapy, Radiation Therapy, Others, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)

This research report (Global Lung Cancer Therapeutics Market) investigates and analyzes the current state and outlook for the global lung cancer therapeutics market over the next five years. It includes information on the overview of the global lung cancer therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include targeted therapy, immunotherapy, chemotherapy, radiation therapy, and others, while the segments by application focus on non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of lung cancer therapeutics. It also includes the market share of major companies in lung cancer therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Glaucoma Treatment

[Research Material] The Global Market for Glaucoma Treatment

Global Market for Glaucoma Treatment: Prostaglandin Analogues (PGA), Beta Blockers, Alpha Agonists, Clinics, Pharmacies, Others

This research report (Global Glaucoma Treatment Market) investigates and analyzes the current state and outlook for the global glaucoma treatment market over the next five years. It includes information on the overview of the global glaucoma treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the glaucoma treatment market focus on prostaglandin analogs (PGA), beta-blockers, and alpha agonists, while the segments by application target clinics, pharmacies, and others. The regional segments calculate the market size for glaucoma treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in glaucoma treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Chemotherapy-Induced Nausea and Vomiting (CINV) Drugs

[Research Material] The Global Market for Chemotherapy-Induced Nausea and Vomiting (CINV) Drugs

World Market for Chemotherapy-Induced Nausea and Vomiting (CINV) Drugs: Aloxi (Palonosetron), Kytril Generics (Granisetron), Emend ...

This research report (Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market) investigates and analyzes the current status and outlook for the global market of chemotherapy-induced nausea and vomiting (CINV) drugs over the next five years. It includes information on the overview of the global chemotherapy-induced nausea and vomiting (CINV) drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Aloxie (Palonosetron), Kytril Generics (Granisetron), Emend (Aprepitant), and Akynzeo (Netupitant-Palonosetron), while the segments by application focus on hematologic cancers, breast cancer, gastrointestinal cancers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of chemotherapy-induced nausea and vomiting (CINV) drugs.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Acute Myeloid Leukemia Treatment Drugs

[Research Material] Global Market for Acute Myeloid Leukemia Treatment Drugs

World Market for Acute Myeloid Leukemia Treatment Drugs: Pipeline Drugs, Chemotherapy Drugs, Chemotherapy Regimens, Hospitals, Clinics, Home Care

This research report (Global Acute Myeloid Leukemia Therapeutics Market) investigates and analyzes the current state and future outlook of the global market for acute myeloid leukemia therapeutics over the next five years. It includes information on the overview of the global acute myeloid leukemia therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include pipeline drugs, chemotherapy drugs, and chemotherapy regimens, while the segments by application focus on hospitals, clinics, and home care. The regional segments calculate the market size for acute myeloid leukemia therapeutics by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the acute myeloid leukemia therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Spirotrichosis Treatment

[Research Material] Global Market for Spirotrichosis Treatment

Global Market for Sporotrichosis Infection Treatment: Itraconazole, Amphotericin B, Saturated Solution of Potassium Iodide (SSKI) ...

This research report (Global Sporothrix Schenckii Infection Treatment Market) investigates and analyzes the current status and outlook for the global market for Sporothrix schenckii infection treatment over the next five years. It includes information on the overview of the global Sporothrix schenckii infection treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include itraconazole, amphotericin B, saturated solution of potassium iodide (SSKI), surgery, and others, while the segments by application focus on hospitals, specialty clinics, surgical centers, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Sporothrix schenckii infection treatment. It also includes the market share of major companies in the Sporothrix schenckii infection treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Gaucher Disease Treatment Drugs

[Research Material] Global Market for Gaucher Disease Treatment Drugs

Global Market for Gaucher Disease Treatments: Enzymes, Glucosylceramide Synthase Inhibitors, Osteoporosis Drugs, Type I Gaucher Disease, Type II Gaucher Disease, II ...

This research report (Global Gaucher Disease Drugs Market) investigates and analyzes the current status and outlook for the global market of Gaucher disease treatment drugs over the next five years. It includes information on the overview of the global Gaucher disease treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Gaucher disease treatment drug market focus on enzymes, glucocerebrosidase inhibitors, and osteoporosis drugs, while the segments by application target Type I Gaucher disease, Type II Gaucher disease, and Type III Gaucher disease. The regional segments calculate the market size for Gaucher disease treatment drugs by dividing into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in Gaucher disease treatment drugs, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Castration-Resistant Prostate Cancer

[Research Material] Global Market for Treatment of Castration-Resistant Prostate Cancer

Global Market for Castration-Resistant Prostate Cancer Treatment: Hormonal Therapy, Anti-Androgen Additions, Anti-Androgen Withdrawal, Estrogen, Chemotherapy, Radiation ...

This research report (Global Castration Resistant Prostate Cancer Treatment) investigates and analyzes the current status and outlook for the global market of castration-resistant prostate cancer treatment over the next five years. It includes information on the global overview of the castration-resistant prostate cancer treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the castration-resistant prostate cancer treatment market include hormone therapy, anti-androgen addition, anti-androgen withdrawal, estrogen, chemotherapy, radiation therapy, and others, while the segments by application focus on hospitals and outpatient surgical centers. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for castration-resistant prostate cancer treatment. The report also includes the market share of major companies in castration-resistant prostate cancer treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Male Pattern Baldness Treatment Drugs

[Research Material] Global Market for Male Pattern Baldness Treatment Drugs

World Market for Male Pattern Baldness Treatment Drugs: RK-023, Refagro, RCH-01, SM-04554, HYG-440, Others, etc.

This research report (Global Androgenic Alopecia Drug Market) investigates and analyzes the current status and outlook for the global market of male pattern baldness treatment drugs over the next five years. It includes information on the overview of the global male pattern baldness treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include RK-023, Refagro, RCH-01, SM-04554, HYG-440, and others, while the segments by application focus on clinics, hospitals, and home use. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for male pattern baldness treatment drugs. The report also includes the market share of major companies in the male pattern baldness treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Systemic Sclerosis Treatment Drugs

[Research Material] Global Market for Systemic Sclerosis Treatment Drugs

Global Market for Systemic Sclerosis Treatment Drugs: Immunosuppressants, Phosphodiesterase 5 Inhibitors - PHA, Endothelin Receptor Antagonists, Prostacyclin ...

This research report (Global Systemic Scleroderma Drugs Market) investigates and analyzes the current status and outlook for the global market of systemic scleroderma treatment drugs over the next five years. It includes information on the overview of the global systemic scleroderma treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include immunosuppressants, phosphodiesterase 5 inhibitors-PHA, endothelin receptor antagonists, prostacyclin analogs, calcium channel blockers, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of systemic scleroderma treatment drugs. It also includes the market share of major companies in the systemic scleroderma treatment drugs sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Non-Hodgkin Lymphoma & Chronic Lymphoma Treatment

[Research Material] Global Market for Non-Hodgkin Lymphoma & Chronic Lymphoma Treatment

World Market for Non-Hodgkin Lymphoma & Chronic Lymphoma Treatment: B Cells, T Cells, Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy, Stem Cell Transplantation

This research report (Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market) investigates and analyzes the current state and outlook for the global market for Non-Hodgkin's Lymphoma and Chronic Lymphoma treatment over the next five years. It includes information on the overview of the global Non-Hodgkin's Lymphoma and Chronic Lymphoma treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Non-Hodgkin's Lymphoma and Chronic Lymphoma treatment market focus on B cells and T cells, while the segments by application cover chemotherapy, immunotherapy, targeted therapy, radiation therapy, and stem cell transplantation. The regional segments calculate the market size for Non-Hodgkin's Lymphoma and Chronic Lymphoma treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the Non-Hodgkin's Lymphoma and Chronic Lymphoma treatment market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Acute Lymphoblastic Leukemia Treatment

[Research Material] Global Market for Acute Lymphoblastic Leukemia Treatment

Global Market for Acute Lymphoblastic Leukemia Treatment: Chemotherapy, Targeted Therapy, Radiation Therapy, Bone Marrow Transplant, Immunotherapy, Others, Adults, Children

This research report (Global Acute Lymphoid Leukemia Treatment Market) investigates and analyzes the current state and outlook for the global market for acute lymphoblastic leukemia treatment over the next five years. It includes information on the overview of the global acute lymphoblastic leukemia treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the acute lymphoblastic leukemia treatment market include chemotherapy, targeted therapy, radiation therapy, bone marrow transplantation, immunotherapy, and others, while the segments by application focus on adults and children. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for acute lymphoblastic leukemia treatment. It also includes the market share of major companies in the acute lymphoblastic leukemia treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Endocrine Therapy Drugs (ETD)

[Research Material] The Global Market for Endocrine Therapy Drugs (ETD)

World Market for Endocrine Therapy Drugs (ETD): Diabetes Medications, Osteoporosis Medications, Contraceptives, Others, Diabetes Treatment, Osteoporosis Treatment, Contraception, Others

This research report (Global Endocrine Therapy Drugs (ETDs) Market) investigates and analyzes the current status and outlook for the global market of endocrine therapy drugs (ETD) over the next five years. It includes information on the overview of the global endocrine therapy drugs (ETD) market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include diabetes medications, osteoporosis medications, contraceptives, and others, while the segments by application focus on diabetes treatment, osteoporosis treatment, contraception, and others. The regional segments calculate the market size of endocrine therapy drugs (ETD) by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in endocrine therapy drugs (ETD), product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Isosorbide Mononitrate

[Research Material] The Global Market for Isosorbide Mononitrate

World Market for Isosorbide Mononitrate: 10mg Tablets, 20mg Tablets, Angina Treatment, Others

This research report (Global Isosorbide Mononitrate Market) investigates and analyzes the current state and outlook for the global isosorbide mononitrate market over the next five years. It includes information on the overview of the global isosorbide mononitrate market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the isosorbide mononitrate market focus on 10mg tablets and 20mg tablets, while the segments by application target angina treatment and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for isosorbide mononitrate accordingly. It also includes the market share of major companies in isosorbide mononitrate, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Undifferentiated Large Cell Lymphoma

[Research Material] Global Market for Treatment of Undifferentiated Large Cell Lymphoma

World Market for Treatment of Undifferentiated Large Cell Lymphoma: Oral, Injection, Hospital, Pharmacy, Others

This research report (Global Anaplastic Large Cell Lymphoma Treatment Market) investigates and analyzes the current state and outlook for the global market for anaplastic large cell lymphoma treatment over the next five years. It includes information on the overview of the global anaplastic large cell lymphoma treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on oral and injectable treatments, while the segments by application target hospitals, pharmacies, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for anaplastic large cell lymphoma treatment. It also includes the market share of major companies in anaplastic large cell lymphoma treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Primary Progressive Multiple Sclerosis Treatment

[Research Material] Global Market for Primary Progressive Multiple Sclerosis Treatment

World Market for One-Time Treatment of Multiple Sclerosis: ApE, Biotin, GZ-402668, Ibudilast, Idebenone, Lakininomod Sodium ...

This research report (Global Primary Progressive Multiple Sclerosis Treatment) investigates and analyzes the current status and outlook for the global market for primary progressive multiple sclerosis treatment over the next five years. It includes information on the global overview of the primary progressive multiple sclerosis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the primary progressive multiple sclerosis treatment market by type include ApE, biotin, GZ-402668, ibudilast, idebenone, lacosamide sodium, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for primary progressive multiple sclerosis treatment. It also includes the market share of major companies in the primary progressive multiple sclerosis treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.